# Takeda invests €300M in plasma-derived therapies site in Lessines, Belgium

Takeda announced an investment of close to 300 million euros to expand its biotechnology manufacturing site in Lessines, Belgium, with a new production facility and a net-zero carbon emissions warehouse.

- Type: Expansion
- Announced: 2022-09-13
- Where: Lessines, Belgium
- Value: $300.0M (300.0M EUR)
- Status: announced
- Products: plasma-derived therapies
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Takeda](https://endata.com/companies/52956.md)

## Sources

- [kickstartbiomanufacturing.be](https://www.kickstartbiomanufacturing.be/success-stories/takeda-invests-close-to-300-million-euros-in-its-plasma-derived-therapies-production-site-in-lessines), 2022-09-13: "The investment of close to 300 million euros encompasses a new production facility and a carbon net-zero emissions warehouse."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.